Dasatinib Combined With Chemotherapy in Relapsed t(8;21) Acute Myeloid Leukemia With KIT D816 Mutation

Exclusion Criteria

• •3. Age is not limited. Both male and female are eligible.
• •4. Eastern Cooperative Oncology Group performance status (ECOG-PS):0-2 point.
• •5. Informed consent form must be signed by patients themselves before enrolled for patients aged 18 years or older. Informed consent form must be signed by the legal guardian for patients younger than 18 years.
• •1. Patients with other blood diseases at the same time (such as haemophilia, primary myelofibrosis and so on) are not considered suitable.
• •2. Isolated extramedullary relapsed leukemia.
• •3. With other malignant tumors accompanied with AML and needed treatment. 4 .Patients who are unsuitable for the trial considered by investigators.